Local Literature Surveillance Challenges and Specifics in the EU, CIS and LATAM regions
Pharmacovigilance legislation introduced by the European Commission in 2012 and GVP guidelines together with local requirements committed each marketing authorization holder (MAH) to perform literature review in countries where their products are present. According to...
Remaining Vigilant and Compliant after Brexit: What’s next? (Latest Updates)
On 29th March 2017 United Kingdom (UK) submitted the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union (EU). This means that the United Kingdom will become a ‘third country’ from 30th March 2019. Even...
